Optics Outfitter
Why this eyewear company’s advertised “starting” prices may not be 20/20.
Vytorin Cholesterol Pill
Merck has agreed to settle two class-action lawsuits filed in 2008 against it and Schering-Plough Corp. (which Merck has since acquired) over its cholesterol medication Vytorin. The settlement is for a whopping $688 million. The two lawsuits were filed by shareholders of the companies and alleged, among other things, that the companies made false and misleading statements regarding the effectiveness and economic success of the drug in press releases and other public disclosures.
The Latest
Court Order Forces Prevagen to Scrub Memory-Improvement Claims
MADISON, CONN. Dec. 12, 2024— In a win for consumers, a court has ordered Quincy Bioscience to stop advertising Prevagen using memory-improvement claims. This follows a near-decade-long campaign by the…
Prevagen Scrubs Memory-Improvement Claims Following Court Order
What led up to brain supplement’s December to remember.
The Perimenopause Gold Rush
Jessica Bennett, The Cut
Friday Plans
Getting lucky for this cheap may be harder than you think.